Pr Arnaud ConstantinRhumatologue à Toulouse

2026Respirology (Carlton, Vic.)PubMed

Effects of Air Pollution Exposure and the MUC5B rs35705950 Variant on Interstitial Lung Disease Risk in Patients With Rheumatoid Arthritis

2026Joint bone spinePubMed

Baseline characteristics of the TRANSLATE2 cohort: A prospective study on rheumatoid arthritis-associated interstitial lung disease

2025The Lancet. RheumatologyPubMed

Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial

2025Life (Basel, Switzerland)PubMed

Beyond Comorbidity: Pulmonary Adenocarcinoma in a Patient with Rheumatoid Arthritis-A Case Report and Literature Review

2025Diagnostics (Basel, Switzerland)PubMed

Predicting Clinical Response to Monoclonal TNF Inhibitors in Rheumatoid Arthritis: A Transcriptomic Approach Based on Transmembrane TNF Reverse Signaling and Nrf2 Activation

2025Annals of the rheumatic diseasesPubMed

Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial

2024Joint bone spinePubMed

2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis

2024Clinical and experimental rheumatologyPubMed

Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts

2024Clinical and experimental rheumatologyPubMed

Two-year treatment persistence with subcutaneous abatacept in rheumatoid arthritis: results from the French cohort of the ASCORE study

2024Arthritis & rheumatology (Hoboken, N.J.)PubMed

Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission

2024Rheumatology (Oxford, England)PubMed

DAS28-γGT for the prediction of major cardiovascular events in rheumatoid arthritis: results from the ESPOIR cohort

2023Arthritis research & therapyPubMed

Ten-year radiographic and functional outcomes in rheumatoid arthritis patients in remission compared to patients in low disease activity

2023Rheumatology (Oxford, England)PubMed

Efficacy of subcutaneous vs intravenous infliximab in rheumatoid arthritis: a post-hoc analysis of a randomized phase III trial

2023Clinical and experimental rheumatologyPubMed

Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohort

2023Rheumatology internationalPubMed

Sjögren's syndrome associated with erosive rheumatoid arthritis alters its prognosis and long-term therapeutic response: a case-control study

2022Arthritis & rheumatology (Hoboken, N.J.)PubMed

A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease

2022Joint bone spinePubMed

Lack of association between the TNFAIP3 rs2230926 variant and rheumatoid arthritis-associated lymphoma

2022Joint bone spinePubMed

Physical activity and rheumatoid arthritis: Need for practical, precise, and personalized support-Results from an online survey

2021RMD openPubMed

Lymphoma complicating rheumatoid arthritis: results from a French case-control study

2021Rheumatology (Oxford, England)PubMed

Impact of disease activity and treatments on ovarian reserve in patients with rheumatoid arthritis in the ESPOIR cohort

2021Rheumatology and therapyPubMed

Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study

2026Rheumatology (Oxford, England)PubMed

Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis atlas

2025Joint bone spinePubMed

Early peripheral psoriatic arthritis: Baseline features of the first 186 patients in the French Nationwide APACHE Cohort

2024Clinical and experimental rheumatologyPubMed

Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts

2024Rheumatology (Oxford, England)PubMed

A prospective survey on therapeutic inertia in psoriatic arthritis (OPTI'PsA)

2026Joint bone spinePubMed

Uselessness of measuring anti-CD74 antibodies and Macrophage Migration Inhibitory Factor in axial spondyloarthritis patients in the DESIR cohort

2026Rheumatology (Oxford, England)PubMed

Time and patient journey to axial spondyloarthritis diagnosis: a retrospective study in French primary care

2025Rheumatology advances in practicePubMed

Bone marrow oedema of the sacroiliac joint without spondyloarthritis: a retrospective study of 34 cases of osteitis condensans ilii

2024Clinical and experimental rheumatologyPubMed

Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts

2024Clinical and experimental rheumatologyPubMed

Two-year treatment persistence with subcutaneous abatacept in rheumatoid arthritis: results from the French cohort of the ASCORE study

2024Rheumatology (Oxford, England)PubMed

Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry

2024Arthritis & rheumatology (Hoboken, N.J.)PubMed

Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission

2023International immunopharmacologyPubMed

Infectious risk when prescribing rituximab in patients with hypogammaglobulinemia acquired in the setting of autoimmune diseases

2026Rheumatology (Oxford, England)PubMed

British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2025

2026The British journal of dermatologyPubMed

British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2025

2025Rheumatology (Oxford, England)PubMed

British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2024

2024The British journal of dermatologyPubMed

British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2024

2026Joint bone spinePubMed

Efficacy and Tolerance of a Combination of Targeted Therapies Indicated for Asthma and Chronic Inflammatory Rheumatism

2025Kidney international reportsPubMed

A Clinicopathological Description of Kidney Features in VEXAS Syndrome

2021iSciencePubMed

Evidence for tmTNF reverse signaling in vivo: Implications for an arginase-1-mediated therapeutic effect of TNF inhibitors during inflammation

2022Rheumatology (Oxford, England)PubMed

New-onset inflammatory bowel diseases among IL-17 inhibitor-treated patients: results from the case-control MISSIL study

2021Rheumatology and therapyPubMed

Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2)

2023Rheumatology (Oxford, England)PubMed

Efficacy of subcutaneous vs intravenous infliximab in rheumatoid arthritis: a post-hoc analysis of a randomized phase III trial

2022Arthritis research & therapyPubMed

Validation in the ESPOIR cohort of vitamin K-dependent protein S (PROS) as a potential biomarker capable of predicting response to the methotrexate/etanercept combination

2025The Lancet. RheumatologyPubMed

Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial

2022Arthritis research & therapyPubMed

Validation in the ESPOIR cohort of vitamin K-dependent protein S (PROS) as a potential biomarker capable of predicting response to the methotrexate/etanercept combination

2025Rheumatology and therapyPubMed

Prevalence and Significance of the Presence of Anti-transglutaminase and Anti-endomysium Antibodies in Patients with Early Inflammatory Joint Disease

2024The Journal of infectionPubMed

Diagnosis and treatment of Tropheryma whipplei infection in patients with inflammatory rheumatic disease: Data from the French Tw-IRD registry

2026Autoimmunity reviewsPubMed

Altered reproductive hormone profiles in systemic lupus erythematosus - A systematic review and meta-analysis

2023Acta endocrinologica (Bucharest, Romania : 2005)PubMed

Estradiol in Systemic Lupus Erythematosus

2023ChestPubMed

Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome

2026Autoimmunity reviewsPubMed

Subtype-specific mortality in idiopathic inflammatory myopathies: A hospital-based cohort

2024The journal of allergy and clinical immunology. In practicePubMed

The Prevalence Of Osteoporosis Is Low in Adult Cutaneous Mastocytosis Patients

2022Frontiers in medicinePubMed

Increased Cardiovascular Risk in Psoriatic Arthritis: Results From a Case-Control Monocentric Study

2023Rheumatology internationalPubMed

Sjögren's syndrome associated with erosive rheumatoid arthritis alters its prognosis and long-term therapeutic response: a case-control study

2026RMD openPubMed

Impact of ANCA specificity on risk of cardiovascular events and death in ANCA-associated vasculitis

2002 · Toulouse 3

Identification de marqueurs génétiques associés à la sévérité de la polyarthrite rhumatoi͏̈de selon une approche gènes candidats

2010 · doctorant : Jean Frédéric Boyer

Étude de l'influence des facteurs de risque traditionnels et de l'inflammation sur le risque cardiovasculaire de la polyarthrite rhumatoïde selon une approche épidémiologique et physiopathologique